Comparison of first-line and second-line use of fingolimod in relapsing MS: The open-label EARLIMS study

Added 649 days ago (14.09.2020)
Authors: Oscar Fernández; Guillermo Izquierdo; Eduardo Aguera; Cristina Ramo; Miguel Hernandez; Diego Silva; Rob Walker; Helmut Butzkueven; Chenyu Wang; Michael Barnett
Read article